TNF and non-small cell lung carcinoma: Although this study, from the perspective of the immune microenvironment (i.e., immune cells, immune-related signatures, immunogenicity, and cytokines) explored the impact of TNFα signaling mutations on the prognosis of NSCLC patients receiving ICIs, there are still some limitations.